Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cimetidine sulfoxide (Cimetidine sulphoxide) is a metabolite of Cimetidine, functioning as a histamine H2-receptor antagonist with potential applications in treating peptic ulcer disease and upper gastrointestinal hemorrhage[1].
Description | Cimetidine sulfoxide (Cimetidine sulphoxide) is a metabolite of Cimetidine, functioning as a histamine H2-receptor antagonist with potential applications in treating peptic ulcer disease and upper gastrointestinal hemorrhage[1]. |
In vitro | Active transport of Cimetidine across the rat small intestine occurs at lower substrate concentrations (40 and 200 μM), becoming obscured by passive transfer at higher concentrations (400 μM). Following certain incubations, Cimetidine sulfoxide is present[2]. |
In vivo | The enantiomeric composition of Cimetidine sulfoxide in male Wistar rats' urine (24 h) was analyzed after administering a dose of 30 mg/kg of Cimetidine (po). The resulting enantiomeric ratio was established at (+/-) 57:43[3]. |
Molecular Weight | 268.34 |
Formula | C10H16N6OS |
CAS No. | 54237-72-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.33 mg/mL (310.54 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cimetidine sulfoxide 54237-72-8 inhibitor inhibit